Physician profile
Patrick M Kane
NPI 1396907838
$2,269.07
in general payments reported to CMS, 2019-2025
15 companies · $1,722 in 2025
The $1,722 reported for 2025 was more than what 81% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $143 · 2020: $14.90 · 2021: $14.02 · 2022: $242 · 2023: $120 · 2024: $13.99 · 2025: $1,722.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,076 · Travel and Lodging: $780.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,076.19 |
| Travel and Lodging | $779.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,806.23 | 2022-2025 | Novostitch, Biosure, Spatial Frame |
| Endo Pharmaceuticals INC. | $99.38 | 2019 | |
| Eclipse Technology Solutions INC. | $53.15 | 2022-2023 | |
| Checkpoint Surgical, INC | $52.26 | 2023 | Checkpoint Stimulators |
| Corium, LLC | $45.26 | 2022-2025 | Azstarys |
| Skeletal Dynamics INC | $34.90 | 2023 | Align, Implate, Ijs |
| Bausch Health US, LLC | $32.09 | 2022 | |
| Vanda Pharmaceuticals INC. | $31.02 | 2025 | Fanapt |
| Baxter Healthcare | $29.31 | 2019 | |
| Ossdsign USA Incorporated | $28.68 | 2025 | Ossdsign Catalyst |
| Allergan, INC. | $14.90 | 2020 | |
| Integra Lifesciences Corporation | $14.02 | 2021 | |
| Life Molecular Imaging Ltd | $13.99 | 2024 | Neuraceq |
| Boston Scientific Corporation | $13.88 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Kane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.